Cell BiologybioRxiv
Drug and siRNA screens identify ROCK2 as a therapeutic target for ciliopathies.
A. V. R. Lake, C. E. L. Smith, S. Natarajan…·C. A. Johnson
The paper identifies ROCK2 as a therapeutic target for ciliopathies through drug and siRNA screens, showing ROCK2 inhibitors could treat cystic kidney disease.
DOI 10.1038/s43856-025-00847-1